{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:41:13Z","timestamp":1776768073575,"version":"3.51.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>A 33-year-old young woman with a rare female appendage tumor of suspected Wolffian origin was initially diagnosed with a benign lesion after the resection of a tubal lesion due to the benign cytomorphology of the tumor tissue. However, 1 year after surgery, she was diagnosed with stage IV fallopian tube cancer due to a recurrence, which presented with substantial ascites and invasion of multiple organs, including the bilateral ovaries, intestines, pelvic peritoneum, greater omentum, and appendix. After tumor cytoreduction, the patient responded well to treatment, which included a regimen of platinum-based drugs combined with docetaxel, aromatase inhibitors such as letrozole, antihormonal therapy, and targeted therapy with bevacizumab.<\/jats:p>","DOI":"10.3389\/fonc.2024.1458817","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:10:12Z","timestamp":1726459812000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Case report: Report of a case of female adnexal malignant tumor of Wolffian origin"],"prefix":"10.3389","volume":"14","author":[{"given":"Shujun","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yufang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhui","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)37427-0","article-title":"Tumors of the broad ligament","volume":"73","author":"Gardner","year":"1957","journal-title":"Am J Obstet Gynecol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/(ISSN)1097-0142","article-title":"Female adnexal tumor of probable Wolffian origin. A distinctive pathologic entity","volume":"31","author":"Kariminejad","year":"1973","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/00313020903273084","article-title":"Is female adnexal tumour of probable wolffian origin a benign lesion","volume":"41","author":"Heatley","year":"2009","journal-title":"A Systematic Rev English Literature Pathol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0046-8177(99)90148-X","article-title":"Wolffian adnexal tumor, so-called female adnexal tumor of probable Wolffian origin (FATWO): immunohistochemical evidence in support of a Wolffian origin","volume":"30","author":"Devouassoux-Shisheboran","year":"1999","journal-title":"Hum Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-8258(03)00228-2","article-title":"Activity of chemotherapy with carboplatin plus paclitaxel in a recurrent mesonephric adenocarcinoma of the uterine corpus","volume":"90","author":"Montagut","year":"2003","journal-title":"Gynecol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gore.2014.07.001","article-title":"A case of metastatic female adnexal tumor of probable Wolffian origin","volume":"10","author":"Deshimaru","year":"2014","journal-title":"Gynecol Oncol Rep"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X19839534","article-title":"Wolffian tumor (female adnexal tumor of Wolffian origin) presenting as a pelvic side wall mass: Report of a case","volume":"7","author":"Rosen","year":"2019","journal-title":"SAGE Open Med Case Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/jog.13704","article-title":"Female adnexal tumor of probable Wolffian origin arising from mesosalpinx: A case report and review","volume":"44","author":"Liu","year":"2018","journal-title":"J Obstet Gynaecol Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.5874","article-title":"Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel\/carboplatin combination chemotherapy: A case report","volume":"13","author":"Wakayama","year":"2017","journal-title":"Oncol Lett"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e3182005340","article-title":"Female adnexal tumor of probable Wolffian origin (FATWO) with recurrence 3 years postsurgery","volume":"30","author":"Syriac","year":"2011","journal-title":"Int J Gynecol Pathol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-2571","article-title":"Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (RESCUE): A nonrandomized, open-label, phase II trial","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s12885-017-3440-0","article-title":"The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole","volume":"17","author":"George","year":"2017","journal-title":"BMC Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.3802\/jgo.2019.30.e86","article-title":"PARAGON (ANZGOG-0903): a phase 2 study of anastrozole in asymptomatic patients with estrogen and progesterone receptor-positive recurrent ovarian cancer and CA125 progression","volume":"30","author":"Kok","year":"2019","journal-title":"J Gynecol Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1458817\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T04:10:14Z","timestamp":1726459814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2024.1458817\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":13,"alternative-id":["10.3389\/fonc.2024.1458817"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2024.1458817","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"article-number":"1458817"}}